Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder

(Abstracted from Female Pelvic Med Reconstr Surg 2018;24:404–407) Intravesical onabotulinumtoxinA (BoNT-A) is used for treatment of idiopathic overactive bladder (iOAB) when conservative measures and medications fail to improve symptoms. After intravesical BoNT-A, the risk of incomplete bladder evacuation (IBE) requiring catheterization is well established.
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: GYNECOLOGY: UROGYNECOLOGY Source Type: research